GroPep licenses technology to TGR B...( the oral mucositis product. GroPep had...)

GroPep licenses technology to TGR BioSciences

the oral mucositis product. GroPep had decided last year to focus our biopharmaceutical development program on our most desirable products PV903 for recurrent miscarriage and PP0102 for psoriasis and other autoimmune diseases. This arrangement will allow continued development of the WGFE technology by a third party." Dr Leanna Read, Managing Director of TGR said "In addition to the oral mucositis project, this new license combined with intellectual property already held by TGR will allow the company to expand its growing commercial product range in the areas of gut and skin health."

What is Oral Mucositis?

Oral mucositis (mouth ulceration and inflammation) is an extremely painful side effect for many patients undergoing chemotherapy and radiotherapy for cancer. For certain cancer treatments almost all patients suffer from this affliction. Mucositis can be so severe that eating, drinking and speech is not possible. Cancer treatment may have to be delayed or suspended completely and infections originating in the mouth can lead to complications or death. An estimated one million people suffer from oral mucositis each year in the United States.

What is WGFE?

Whey Growth Factor Extract (WGFE) is a biologically active milk extract of naturally occurring proteins known to be fundamental to the tissue healing process.

'"/>

Contact: Tony Mitchell
investorrelations@gropep.com.au
61-883-547-700
Research Australia
26-Jul-2005

Page: 1 2
Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. GroPep to pursue promising asthma drug following preclinical study results
5. GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug
6. Doctors working overseas face having licenses removed
7. UW licenses innovated cardiovascular software to VPDiagnostics
8. The Wistar Institute licenses rubella vaccine seed stock to Microgen of Russia
9. MCW Research Foundation licenses invention for stroke treatment
10. Wireless technology shows promise in diagnosing pediatric intestinal disease
11. Speeding up CT scans with cellphone technology, ultrasound warning signal for breast cancer

Post Your Comments:

(Date:8/15/2019)... WASHINGTON (PRWEB) , ... August 15, 2019 , ... ... following statement: , "The deadline for family planning clinics to provide written ... next Monday, August 19. Similar to the Global Gag Rule, the new ...

(Date:8/14/2019)... ... August 15, 2019 , ... R3 Stem ... Mexico. R3 Stem Cell International is offering regenerative procedures with mesenchymal stem cells ... full procedure costs only $2950, which includes a complete IV therapy or two ...

(Date:8/14/2019)... ... , ... While it is commonly understood that good nutrition promotes general health, ... them manage and, in some cases, reverse certain medical conditions, according to health and ... adults are trying to manage a health or medical condition by making healthy food ...

(Date:8/12/2019)... ... 12, 2019 , ... Ziegler, a specialty investment bank, is ... Lesley University, which is currently rated A-/Stable through S&P. Issued through the Massachusetts ... to refund the outstanding debt on the Series 2011 bonds, the Series 2012 ...

(Date:8/9/2019)... (PRWEB) , ... August 09, 2019 , ... ... providing nutrition and lifestyle solutions, has announced its second round of U.S. finalists ... second-round finalists are Chris Robinson of Waxhaw, North Carolina; Kristyn Koegel of Mebane, ...

Breaking Medicine News(10 mins):

[0] Catholics for Choice: Trump Administration Attacks Title X Funding, Threatening Healthcare Access for Millions of Americans [0] R3 Stem Cell International Now Offering Procedures in Mexico [0] U.S. Consumers’ Desire to Use Food as Medicine Is Evidenced by Emerging Superfoods [0] Ziegler Closes $56.595 Million Series 2019 Bonds For Lesley University [0] Five New U.S. Finalists Named in IsaBody Challenge To Compete for $25,000

(Date:8/14/2019)... ... , ... Cambria Solutions, Inc., an award-winning national technology and management ... The Inc. 5000 is the most prestigious ranking of the nation’s fastest-growing private companies. ... “We have a committed and expanding team with a growth mindset that contributes to ...

(Date:8/14/2019)... ... 2019 , ... A recent worldwide study has significantly advanced ... the leading causes of infertility in women[1]. Dr. Mark Trolice, Director ... the first genetic evidence of a causal link between PCOS and depression[2]. , ...

(Date:8/12/2019)... ... August 12, 2019 , ... Dr. Kenrick Spence is ... in the field of cosmetic plastic and reconstructive surgery, Dr. Spence serves patients ... for his knowledge and expertise in treating keloid scars . The USA ...

Breaking Medicine Technology:

[0] Cambria Solutions Recognized by Inc. Magazine as a Fastest-Growing Private Company – the Inc. 5000 [0] Research Breakthrough May Lead To Early Diagnosis of PCOS [0] Orlando Plastic Surgeon Dr. Kenrick Spence Featured in USA Today

Cached News:

Purdue chemical-analysis method promises fast results Grieving parents at increased suicide risk 'Spirituality' is related to depression among young physicians The world health organization launches new stop TB strategy in the Lancet

Dental students help close care gap at Indian reservation 3-D echocardiography reduces examination times and dramatically improves,accuracy of the most common diagnostic test for heart function Food should be fortified with folic acid to ensure all mothers receive recommended daily requirements Women at high risk for breast cancer may avoid mammograms